DENTSPLY SIRONA Inc. Forecasted to Post FY2024 Earnings of $2.01 Per Share (NASDAQ:XRAY)

DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) – Analysts at Leerink Partnrs cut their FY2024 EPS estimates for DENTSPLY SIRONA in a research report issued on Thursday, May 2nd. Leerink Partnrs analyst M. Cherny now anticipates that the medical instruments supplier will post earnings of $2.01 per share for the year, down from their prior estimate of $2.06. Leerink Partnrs has a “Outperform” rating on the stock. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $2.04 per share. Leerink Partnrs also issued estimates for DENTSPLY SIRONA’s FY2025 earnings at $2.40 EPS, FY2026 earnings at $2.75 EPS and FY2027 earnings at $3.07 EPS.

Other analysts have also issued reports about the stock. Piper Sandler reaffirmed a “neutral” rating and set a $32.00 price target (down from $35.00) on shares of DENTSPLY SIRONA in a research report on Friday. Robert W. Baird dropped their price objective on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a research report on Friday. Evercore ISI reduced their target price on shares of DENTSPLY SIRONA from $40.00 to $35.00 and set an “outperform” rating for the company in a report on Friday. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Friday. Finally, SVB Leerink initiated coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They set an “outperform” rating and a $42.00 price objective for the company. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $35.22.

Check Out Our Latest Stock Analysis on DENTSPLY SIRONA

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY opened at $28.25 on Monday. DENTSPLY SIRONA has a 52 week low of $26.27 and a 52 week high of $41.65. The stock has a market capitalization of $5.87 billion, a PE ratio of -64.20, a price-to-earnings-growth ratio of 1.24 and a beta of 1.00. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.97 and a current ratio of 1.43. The stock has a 50 day moving average price of $32.02 and a 200 day moving average price of $32.69.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last announced its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.42. The firm had revenue of $953.00 million during the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. The company’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same period in the prior year, the business earned $0.39 EPS.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several institutional investors and hedge funds have recently added to or reduced their stakes in XRAY. VisionPoint Advisory Group LLC raised its position in DENTSPLY SIRONA by 104.2% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after purchasing an additional 395 shares during the last quarter. Principal Securities Inc. acquired a new stake in shares of DENTSPLY SIRONA in the fourth quarter valued at about $26,000. Headlands Technologies LLC bought a new position in shares of DENTSPLY SIRONA during the fourth quarter worth about $30,000. Parkside Financial Bank & Trust lifted its stake in shares of DENTSPLY SIRONA by 33.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock worth $42,000 after acquiring an additional 292 shares during the period. Finally, Anchor Investment Management LLC acquired a new stake in DENTSPLY SIRONA during the 4th quarter valued at approximately $47,000. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Stockholders of record on Friday, March 29th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.27%. The ex-dividend date of this dividend was Wednesday, March 27th. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. DENTSPLY SIRONA’s dividend payout ratio is -145.45%.

DENTSPLY SIRONA Company Profile

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Further Reading

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.